xaliproden has been researched along with Degenerative Diseases, Central Nervous System in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Müller, T; Porzner, M; Seufferlein, T | 1 |
1 review(s) available for xaliproden and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
SR 57746A/xaliproden, a non-peptide neurotrophic compound: prospects and constraints for the treatment of nervous system diseases.
Topics: Animals; Clinical Trials as Topic; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Naphthalenes; Neurodegenerative Diseases; Neuroprotective Agents; Pyridines | 2009 |